Picture of Indivior Pharmaceuticals logo

INDV — Indivior Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapSuper Stock

Brief: Indivior Proposes New Corporate Structure To Achieve U.S. Domiciliation

Oct 1 (Reuters) - Indivior PLC 2IVB.D:

INDIVIOR PROPOSES NEW CORPORATE STRUCTURE TO ACHIEVE U.S. DOMICILIATION

INDIVIOR PLC - TO CHANGE DOMICILE FROM U.K. TO U.S.

INDIVIOR PLC - SHAREHOLDERS TO RECEIVE ONE IPI SHARE PER PLC SHARE

INDIVIOR PLC: NO ADDITIONAL EQUITY WILL BE RAISED BY IPI AS PART OF TRANSACTION

INDIVIOR PLC: INDIVIOR PLC WILL BECOME A DIRECT WHOLLY OWNED SUBSIDIARY OF IPI

INDIVIOR: WILL ESTABLISH NEW U.S. PARENT CO, INDIVIOR PHARMACEUTICALS, ABOVE EXISTING UK PARENT CO

INDIVIOR PLC - EXPECTS SCHEME EFFECTIVE JANUARY 2026, PLC SHARES EXCHANGED FOR IPI

INDIVIOR: IPI'S STOCK WILL BE LISTED ON NASDAQ AND WILL CONTINUE TO TRADE UNDER SYMBOL INDV

Source text: ID:nPn9WnRrMa

Further company coverage: 2IVB.D

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Indivior Pharmaceuticals

See all news